Dompe Release: The First Patient Has Been Enrolled in the First International Clinical Trial of rhNGF for the Treatment of Neurotrophic Keratitis
2/14/2013 9:52:36 AM
More...
|
Dompé: The First International Clinical Ophthalmological Trial Concerning Treatment of Neurotrophic Keratitis (NK), an Ocular Pathology With No Cure, Takes Place in Italy
9/7/2012 10:25:56 AM
More...
|
AAA Acquires Rights to Oncology Antibody Treatment Fabovar from Dompe
8/1/2011 10:02:08 AM
More...
|
Dyax Corp. (DYAX) Enters into an Exclusive Negotiation Period with Dompe for European License to DX-88 in Angioedema Indications
7/15/2008 6:24:32 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Announces Manufacturing Agreement with Dompe for PRX321
7/17/2007 3:23:52 PM
More...
|
AltaRex Medical Corp. (ALXMF.PK) Signs Distribution Agreement With Dompe
10/19/2005 5:08:56 PM
More...
|